Furthermore, IL8 transcript levels progressively increased with NASH advancement, as indicated by the fibrosis stage, NAFLD activity score, and Brunt fibrosis grade (Figure 1C). This evidence concerns the gene CXCL8 and metabolic dysfunction-associated steatotic liver disease.